You are here

  • Home
  • Archive
  • Volume 15, Issue Suppl 2
  • 000101 PACLITAXEL/CARBOPLATIN (TC) VS. PACLITAXEL/CARBOPLATIN FOLLOWED BY TOPOTECAN (TOP) IN FIRST-LINE TREATMENT OF OVARIAN CANCER FIGO STAGES IIB-IV. MATURE RESULTS OF AN INTERGROUP PHASE III TRIAL

Article info

Article menu
Download PDFPDF
Oral Presentations – Thursday, September 29, 2005
000101 PACLITAXEL/CARBOPLATIN (TC) VS. PACLITAXEL/CARBOPLATIN FOLLOWED BY TOPOTECAN (TOP) IN FIRST-LINE TREATMENT OF OVARIAN CANCER FIGO STAGES IIB-IV. MATURE RESULTS OF AN INTERGROUP PHASE III TRIAL

Authors

Citation

Lück HJ, Weber B, Quaas J, et al
000101 PACLITAXEL/CARBOPLATIN (TC) VS. PACLITAXEL/CARBOPLATIN FOLLOWED BY TOPOTECAN (TOP) IN FIRST-LINE TREATMENT OF OVARIAN CANCER FIGO STAGES IIB-IV. MATURE RESULTS OF AN INTERGROUP PHASE III TRIAL
International Journal of Gynecologic Cancer 2005;15:79.
Online issue publication 
December 17, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2005 IGCS